Pfizer (PFE) Tops Q4 EPS by 1c
Get Alerts PFE Hot Sheet
Price: $25.26 -3.84%
Revenue Growth %: -23.7%
Financial Fact:
Selling, informational and administrative expenses: 3.56B
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: -23.7%
Financial Fact:
Selling, informational and administrative expenses: 3.56B
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q4 EPS of $0.53, $0.01 better than the analyst estimate of $0.52. Revenue for the quarter came in at $14.05 billion versus the consensus estimate of $13.57 billion.
Guidance:
The Company sees FY16 EPS of $2.20 - $2.30 and revenue of $49 - $51 billion. The Street is looking for EPS of $2.36 and revenue of $52.5 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intel (INTC) tops Q1 EPS by 3c; misses on guidance
- Eastman Chemical (EMN) Tops Q1 EPS by 18c, provides guidance
- Atlassian (TEAM) Tops Q3 EPS by 30c, provides guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!